PRMT1 promotes the tumor suppressor function of p14(ARF) and is indicative for pancreatic cancer prognosis.
PRMT1 promotes the tumor suppressor function of p14(ARF) and is indicative for pancreatic cancer prognosis.
复制标题
PRMT1 促进 p14(ARF) 的肿瘤抑制功能,并指示胰腺癌的预后。
DOI:
10.15252/embj.2020106777
复制
发表时间:
2021-07-01
期刊:
影响因子:
--
通讯作者:
Bauer UM
中科院分区:
文献类型:
--
作者:
Repenning A;Happel D;Bouchard C;Meixner M;Verel-Yilmaz Y;Raifer H;Holembowski L;Krause E;Kremmer E;Feederle R;Keber CU;Lohoff M;Slater EP;Bartsch DK;Bauer UM
The p14ARF protein is a well‐known regulator of p53‐dependent and p53‐independent tumor‐suppressive activities. In unstressed cells, p14ARF is predominantly sequestered in the nucleoli, bound to its nucleolar interaction partner NPM. Upon genotoxic stress, p14ARF undergoes an immediate redistribution to the nucleo‐ and cytoplasm, where it promotes activation of cell cycle arrest and apoptosis. Here, we identify p14ARF as a novel interaction partner and substrate of PRMT1 (protein arginine methyltransferase 1). PRMT1 methylates several arginine residues in the C‐terminal nuclear/nucleolar localization sequence (NLS/NoLS) of p14ARF. In the absence of cellular stress, these arginines are crucial for nucleolar localization of p14ARF. Genotoxic stress causes augmented interaction between PRMT1 and p14ARF, accompanied by arginine methylation of p14ARF. PRMT1‐dependent NLS/NoLS methylation promotes the release of p14ARF from NPM and nucleolar sequestration, subsequently leading to p53‐independent apoptosis. This PRMT1‐p14ARF cooperation is cancer‐relevant and indicative for PDAC (pancreatic ductal adenocarcinoma) prognosis and chemotherapy response of pancreatic tumor cells. Our data reveal that PRMT1‐mediated arginine methylation is an important trigger for p14ARF’s stress‐induced tumor‐suppressive function. Arginine methylation in the nuclear/nucleolar localization sequence regulates intracellular redistribution and promotion of p53‐independent apoptosis by of p14ARF.